Hancock Jaffe Laboratories Inc. (HJLI) is priced at $0.33 after the most recent trading session. At the very opening of the session, the stock price was $0.3285 and reached a high price of $0.3343, prior to closing the session it reached the value of $0.34. The stock touched a low price of $0.3221.
Recently in News on November 5, 2020, Hancock Jaffe Announces Date for VenoValve Pre-IDE Meeting with FDA. Meeting with FDA Set for December 22. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Hancock Jaffe Laboratories Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.8500 on 01/08/20, with the lowest value was $0.2111 for the same time period, recorded on 03/24/20.
Hancock Jaffe Laboratories Inc. (HJLI) full year performance was -43.11%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Hancock Jaffe Laboratories Inc. shares are logging -61.18% during the 52-week period from high price, and 56.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.21 and $0.85.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1121413 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Hancock Jaffe Laboratories Inc. (HJLI) recorded performance in the market was -40.00%, having the revenues showcasing 17.52% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 16.89M, as it employees total of 12 workers.
Hancock Jaffe Laboratories Inc. (HJLI) in the eye of market guru’s
During the last month, 0 analysts gave the Hancock Jaffe Laboratories Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.3788, with a change in the price was noted -0.0599. In a similar fashion, Hancock Jaffe Laboratories Inc. posted a movement of -15.36% for the period of last 100 days, recording 8,213,654 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for HJLI is recording 0.75 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Hancock Jaffe Laboratories Inc. (HJLI): Stocks Technical analysis and Trends
Raw Stochastic average of Hancock Jaffe Laboratories Inc. in the period of last 50 days is set at 11.17%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 38.64%. In the last 20 days, the company’s Stochastic %K was 28.02% and its Stochastic %D was recorded 26.42%.
If we look into the earlier routines of Hancock Jaffe Laboratories Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -40.00%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -8.84%, alongside a downfall of -43.11% for the period of the last 12 months. The shares increased approximately by -3.54% in the 7-day charts and went up by -11.03% in the period of the last 30 days. Common stock shares were driven by 17.52% during last recorded quarter.